Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stadnicki

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Gut|December 24, 1998
Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis ratsA Stadnicki, R B Sartor, R Janardham, et al.
Immunopharmacology|June 1, 1996
Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: correlation with the cytokine profileR A DeLa Cadena, A Majluf-Cruz, A Stadnicki, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 1998
Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible ratsA Stadnicki, R B Sartor, R Janardham, et al.
Proceedings of the Association of American Physicians|January 1, 1997
Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitorR W Colman, A Stadnicki, C A Kettner, et al.
The American Journal of Physiology|October 2, 1998
Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis ratsA Stadnicki, J Chao, I Stadnicka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 1995
Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis ratR A Dela Cadena, A Stadnicki, A B Uknis, et al.
Digestive Diseases and Sciences|December 17, 1997
Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitisA Stadnicki, M Gonciarz, T J Niewiarowski, et al.
Digestive Diseases and Sciences|May 1, 1996
Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis ratA Stadnicki, R A DeLa Cadena, R B Sartor, et al.
Menopause International|September 6, 2007
Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal womenL A Mattsson, S Skouby, M Rees, et al.
Thrombosis and Haemostasis|July 31, 1998
Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humansR A DeLa Cadena, A Majluf-Cruz, A Stadnicki, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Gut|December 24, 1998
Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis ratsA Stadnicki, R B Sartor, R Janardham, et al.
Immunopharmacology|June 1, 1996
Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: correlation with the cytokine profileR A DeLa Cadena, A Majluf-Cruz, A Stadnicki, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 1998
Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible ratsA Stadnicki, R B Sartor, R Janardham, et al.
Proceedings of the Association of American Physicians|January 1, 1997
Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitorR W Colman, A Stadnicki, C A Kettner, et al.
The American Journal of Physiology|October 2, 1998
Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis ratsA Stadnicki, J Chao, I Stadnicka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 1, 1995
Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis ratR A Dela Cadena, A Stadnicki, A B Uknis, et al.
Digestive Diseases and Sciences|December 17, 1997
Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitisA Stadnicki, M Gonciarz, T J Niewiarowski, et al.
Digestive Diseases and Sciences|May 1, 1996
Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis ratA Stadnicki, R A DeLa Cadena, R B Sartor, et al.
Menopause International|September 6, 2007
Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal womenL A Mattsson, S Skouby, M Rees, et al.
Thrombosis and Haemostasis|July 31, 1998
Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humansR A DeLa Cadena, A Majluf-Cruz, A Stadnicki, et al.
Pageof 4